Quantification of second generation direct-acting antivirals daclatasvir, elbasvir, grazoprevir, ledipasvir, simeprevir, sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS von van Seyen, Minou, de Graaff Teulen, Marga J.A., van Erp, Nielka P., Burger, David M.

Volltext

Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and... von Bollen, Pauline D.J., de Graaff-Teulen, Marga J.A., Schalkwijk, Stein, van Erp, Nielka P., Burger, David M.

Volltext

Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects von Lee, Manon J., Dawood, Lara, Hofstede, Hadewych J.M., Graaff‐Teulen, Marga J.A., Ewijk‐Beneken Kolmer, Eleonora W.J., Caliskan‐Yassen, Nurcan, Koopmans, Peter P., Burger, David M.

Volltext

Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244) von JONKMAN-DE VRIES, J. D, DE GRAAFF-TEULEN, M. J. A, HENRAR, R. E. C, KETTENES-VAN DEN BOSCH, J. J, BULT, A, BEIJNEN, J. H

Volltext